Everolimus in the management of metastatic neuroendocrine tumours
Neuroendocrine tumours are increasing in incidence and cause a variety of symptoms. The mammalian target of rapamycin (mTOR) pathway plays a key role in neuroendocrine tumour (NET) pathogenesis, leading to increased lipid synthesis, protein synthesis and cellular growth. Upregulation of this pathway...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publishing
2017-01-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Acceso en liña: | https://doi.org/10.1177/1756283X16674660 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|